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ABSTRACTSBetween the SCP and SpR groups therewas no difference in (1) mean intra-
operative re-transfusion (598ml vs 636ml p¼0.44), (2) mean post-opera-
tive haemoglobin drop (2.32g/dl vs 2.29g/dl, p¼0.92), and (3) mean
operating time (137.9min vs 141.7min, p¼0.57).
Conclusions: As an assistant, there is no difference between the SCP and
SpR. Our data supports using the SCP as an experienced ﬁrst assistant to
the experienced SpR for training.
0723: SURGICAL OUTCOMES OF NEPHRON SPARING SURGERY FOR
RENAL TUMOURS
Anna Mainwaring, Ninaad Awsare, Pradeep Bose, Neil Fenn, Jonathan
Featherstone. Morriston Hospital, Swansea, UK
Aim: Nephron sparing surgery (NSS) is increasingly being performed to
treat renal tumours. We reviewed our surgical outcomes following partial
nephrectomy.
Methods:A retrospective reviewof 51 consecutive patients (median age 59
years) undergoing NSS for renal tumours between 1999 and 2011. Indica-
tions for NSSwere absolute (n¼14), relative (n¼16) or elective (n¼21). Data
collected included peri-operative, histological, disease-free and overall
survival data. Complicationswere recorded using the Clavien classiﬁcation.
Results: Most procedures were performed open (n¼46). More recently
selected cases have been performed laparoscopically (n¼5). There were no
peri-operativedeathsandnopatients required renaldialysis. Sixteenpatients
(31%) had post-operative complications. Of these, 8 were Grade 1, 5 were
Grade2 and3wereGrade 3aaccording to theClavien classiﬁcation.Histology
conﬁrmed 37(73%) tumours were malignant and 14(27%) were benign.
During follow up there were no local recurrences, but 1 patient (3%) devel-
opedmetastatic disease. The overall survival rate at amedian follow up of 31
monthswas 92%with only one death attributable tometastatic renal cancer.
Conclusion: NSS for renal tumours is safe with an acceptable peri-oper-
ative morbidity rate. Preservation of renal function and low recurrence
rates conﬁrm it is an effective treatment option.
0755: CAN URINE CYTOLOGY BE SAFELY OMITTED FROM ROUTINE
WORK-UP FOR HAEMATURIA?
Eleni Anastasiadis 2, Dhili Arul 1, Kara Bruce-Hickman 1, Sudhanshu
Chitale 1, M. Ghei 1, Barry Maraj 1. 1Whittington Health, London, UK; 2 St
George's Healthcare Trust, London, UK
Introduction / Aim: Urine cytology has traditionally been part of routine
work-up for patients with haematuria but provided relatively limited
diagnostic yield at a signiﬁcant cost. We audited our practice in the local
setting to assess the value of urine cytology and the implications of
deleting it from the investigative pathway.
Method: Clinical data for 191 patients referred for urine cytological
examination over a period of 3 months (July – September 2010) was
collected from the hospital database.
Results: Haematuria was the presentation in 138 (73%) of these requests.
69% (95/138) were from Urologists. Of the 138, 77% were reported normal,
4% revealed atypical cells, 3% had malignant cells, 8% had appearances
indicative of inﬂammatory pathology and 8% were unsuitable for analysis.
Positive yield was < 10%. Of the 7% (9/138) with proven urothelial cancer
(only of bladder in this series), cytology was normal in 44%, atypical in 11%,
and malignant in 33%, highlighting that cytology would have missed
cancer in >50% of haematuria cases.
Conclusion: Urine cytology has very poor sensitivity for diagnosing uro-
thelial cancer, and the cost and effort to conduct this investigation does not
justify its use in the routine work-up of patients with haematuria.
0769: INCIDENTAL SYNCHRONOUS PRIMARY TUMOURS DETECTED
DURING A MODIFIED MRI PROSTATE PROTOCOL
Paul Hughes, Rajesh Nair, Tim Larner. Brighton and Sussex University
Hospitals NHS Trust, Brighton, UK
Introduction: Magnetic resonance imaging (MRI) is the cross-sectional
imaging modality of choice in staging prostate cancer. Standard protocol
for prostate MRI is limited to the pelvis. We describe beneﬁts of extended
MRI protocols in identifying incidental synchronous primary lesions,
which potentially inﬂuence prostate cancer management.
Patients & Methods: A retrospective single-center review of 464 patients
(median age 68, range 47-82 years) with a diagnosis of prostate cancerbetween January 2008 and December 2011 was performed. Outcomes
were reviewed in patients that underwent extended-MRI staging inwhom
synchronous abdominal and pelvic masses were identiﬁed.
Results: Eight patients had synchronous lesions identiﬁed: one adrenal
mass, one rectal cancer, two bladder cancers and four renal masses. The
adrenal mass was a non-functioning adenoma and one renal mass was
identiﬁed as a simple cyst. The remaining six cases (1.3%) had conﬁrmed
synchronous malignancies. In two patients this did not inﬂuence prostate
cancer management. The patients with rectal cancer and muscle invasive
bladder cancer would have been identiﬁed with conventional protocols.
The two patients with advanced renal malignancy were identiﬁed due to
extended MRI.
Conclusion: Signiﬁcant renal lesions were identiﬁed on extended-MRI
staging protocols for prostate cancer. These synchronous malignancies
potentially inﬂuence prostate cancer management.
0772: THE ROLE OF CONTRAST ENHANCED ULTRASOUND IN THE
ASSESSMENT OF COMPLEX OR EQUIVOCAL RENAL LESIONS
Paul Hughes, Rajesh Nair, Emma Simpson, Tim Larner. Brighton and Sussex
University Hospitals, Brighton, UK
Introduction: Contrast enhanced computed tomography (CECT) remains
the standard imaging modality for renal lesion characterisation. Circum-
stances however, exist where diagnostic uncertainty remains. Contrast
enhanced ultrasound (CEUS) is a safe, affordable, non-ionising adjunct in
the assessment of difﬁcult renal lesions. We describe our experience with
this emerging radiological technique.
Material andMethods:A single-centre retrospective reviewof 21 patients,
median age of 68 years (range 35-89 years) with equivocal renal lesions
was performed. All patients underwent CEUS using sonovuemicro-bubbles
between November 2010 and August 2011. Renal lesion enhancement,
clinical outcomes and histological correlation were analysed.
Results: In six patients with complex cystic renal lesions, three demon-
strated concerning enhancement. In thirteen cases with equivocal solid
lesions, nine were suggestive of renal cell carcinoma (RCC) of which ﬁve
underwent nephrectomy. Three lesions demonstrated no enhancement.
Only in one case was a lesion felt to be equivocal necessitating further
imaging. Two cases were post-cryotherapy ablation, of which one
demonstrated recurrence not accessible on CECT. CEUS aided clinical
decision-making in 90% (19/21) of cases.
Conclusion: CEUS is an important adjunct to conventional imaging in
delineating the nature of complex renal lesions, particularly those with
renal impairment, when contrast agents are contra-indicated.
0797: THE IMPORTANCE OF THE BIOPSY OF NORMAL APPEARING
BLADDER MUCOSA AT THE EDGE OF PRIMARY TUMOUR RESECTION
SITE
Asheesh Kaul, Chris Jacobs, Michal Sut, Aasem Chaudry. Bedford Hospital
NHS Trust, Bedford, UK
Introduction: European Association of Urology guidelines advocate
separate biopsy of tumour base and edge during initial transurethral
resection of bladder tumour (TURBT). Most evidence available analyse the
prognostic value of random bladder biopsies rather than edge of resection
site speciﬁcally.
Aim: To evaluate the incidence and signiﬁcance of positive tumour edge
biopsies at primary TURBT.
Methods: 22 cases of primary TURBT performed between October 2010
and October 2011 were retrospectively reviewed. All resections included
a routine cold-cup biopsy of macroscopically normal mucosa at the
resection edge. Data sources included histopathology reports and Multi-
disciplinary Team Meeting notes.
Results: Abnormal biopsy was found in 9 patients (41%). Carcinoma-in-
situ (CIS) was found in 7 patients (32%) and in 2 cases (9%) biopsy results
were corresponding with primary pathology indicating incomplete
tumour resection.
Tumour edge biopsy effected management of 3 cases (22%). 2 patients (9%)
with CIS received intravesical chemotherapy with Bacillus Calmette-Gue-
rin (BCG) vaccine and 1 patient with incomplete resection underwent early
check cystoscopy and biopsy within 3 weeks of primary resection. Those
patients would otherwise have been scheduled for check cystoscopy at 3
months.
Abstracts / International Journal of Surgery 10 (2012) S53–S109S100
ABSTRACTSConclusion: We believe that tumour edge biopsy should be standard
practice at primary TURBT.
0813: DOES THE 2 WEEK WAIT REFERRAL PROCESS HAVE AN IMPACT
ON BLADDER CANCER PROGNOSIS?
Sherief Marzouk, Ali Jibran Mecci, Jo Han Gan, Paula Allchorne, Benjamin
Lamb, James Green. Whipps Cross University Hospital, London, UK
The twoweekwait (2WW)pathwayhas been successful in reducing time to
treatment for bladder cancer.However there are still a signiﬁcant numberof
patients who present as emergencies with frank haematuria. We sought to
establishwhether there is a signiﬁcant difference inprognostic indicators of
bladder TCC at presentation between the patients referred to the 2WW
haematuria clinic and those presenting as emergencies.
We performed a retrospective cohort study of patients referred with
haematuria, comparing tumour stage and grade between patients referred
as emergencies and to 2WW haematuria clinics. Only diagnoses of TCC
were included.
354 patients presented to A&E with frank haematuria from September
2009 to September 2011. 67 had bladder TCC with 51 new diagnoses,
whereas 146 TCCs were diagnosed through 2WW clinic. Of the emergency
group 55% had muscle invasive tumours compared to 23% from clinic (p ¼
<0.001). The same was true for tumour grade: 79% G3 as emergencies
versus 54% from clinic (p ¼ <0.001).
We found that patients with TCC that present as emergencies had far
worse prognostic indicators at presentation. This supports the need for the
inclusion of haematuria in the out of hours urology guidelines within the
Acute Oncology Service.
0827: THE INTRODUCTION OF HOLEP TO A DGH: IMPROVED OUTCOMES
FOR HOLEP AND CONCURRENT TURP PATIENTS
Nicholas Wilson, Michael Mikhail, Anthony Young. Southend University
Hospital, Southend, UK
Introduction: Both Holmium laser enucleation of the prostate (HoLEP)
and TURP are recommended by NICE as surgical treatment options for
symptomatic benign prostatic enlargement. Three years ago HoLEP was
introduced to our institution alongside TURP. The aim of this study was to
examine the effect of introducing HoLEP on: resection weight, length of
stay (LOS) and transfusion rate, and also examine what impact this had on
patients concurrently undergoing TURPs.
Methods:We retrospectively analysed all TURPs (TURP-08-11) and HoLEPs
performed at our unit from the introduction of HoLEP in April 2008 to July
2011. We also analysed all TURPs in the 12 months preceding April 2008 to
form a historical control (TURP-07).
Results: A total of 769 procedures were performed: 161 TURP-07, 425
TURP-08-11, and 183 HoLEP. The rate of transfusionwas 5.5%, 2.2% and 1.6%
in the TURP-07, TURP-08-11 and HoLEP groups, respectively. The median
LOS for HoLEP was 3 days compared to 5.6 and 4.4 for TURP-07 and TURP-
08-11, respectively.
Conclusion: The introduction of HoLEP alongside TURP has signiﬁcantly
reduced LOS and transfusion rates for all patients. HoLEP patients had the
largest reductions, but notably TURPs done in an institution also per-
forming HoLEP showed signiﬁcant improvements in outcomes as well.
0880: MAPPING PROSTATE BIOPSIES DOES NOT INCREASE THE
ACCURACY OF PROSTATE CANCER STAGING
Nirav Patel, Evangelos Gkougkousis, James Green. Urology department,
Whipps Cross Hospital, London, UK
Aim: Performing a stagingMRI in the presence of positive apical biopsies is
a standard practice in many prostate cancer centres. We aimed to assess
the value of mapping prostate biopsies.
Method: Data from 206 patients diagnosed with prostate cancer between
January 2010 and September 2011 were retrospectively collected. Pre-
senting PSA, clinical stage, Gleason score, apical positivity and imaging
results were analyzed using Chi square test on SPSS 20.
Results: One hundred and twenty seven of 159 patients with apical
involvement and 29 of 47 without had an MRI of the pelvis, with extrap-
rostatic disease found in 43 and 6 patients respectively (p¼0.186). This
difference was not statistically signiﬁcant even stratifying for PSA level and
Gleason score. In multivariate analysis, the largest subgroup comprisedpatients with PSA 10 and Gleason 6 or 7, where again results were not
signiﬁcant (p¼0.516 and 0.525 respectively). Similarly, bone scan results
were comparable, with 11 of 87 patients with positive apex and 2 of 18
with negative apex having bone metastases (p¼0.283)
Conclusion: Our data shows that mapping prostate biopsies and per-
forming an MRI in the presence of apical involvement does not increase
the accuracy of prostate cancer staging.
0918: THE ROLE OF AN ENHANCED RECOVERY PROGRAMME FOR
PATIENTS UNDERGOING RADICAL CYSTECTOMY
Amit Gupta, Raj Nair, Sam Jallad, Philip Thomas, Tim Larner. Brighton and
Sussex University Hospitals NHS Trust, Brighton, UK
Aim: An Enhanced Recovery Programme (ERP) reduces hospital stay, and
improves peri-operative complication rates in colonic resection patients.
Its role in urological surgery however, has been the subject of debate.
We examine the role of an ERP tailored to radical cystectomy at a tertiary
centre.
Method: A retrospective review of 32 cystectomies (November 2009 -
September 2011).16 ERP cases (median age 69, range 56 – 76) were
compared to 16 non-ERP cases (median age 69, range 65 – 80). Co-
morbidities were quantiﬁed using the Charlson Co-morbidity Index (CCI).
Outcome measures included time to oral nutrition, bowel action, mobi-
lisation, discharge and complications.
Results: There was no statistical difference in CCI between the two groups.
Median ERPdischargewas day 14 (range 7 - 44) compared to day18 (range 9 -
24) in the non-ERP patients. Median date of ERP patients achieving oral
consumptionwasday6compared today8 innon-ERPpatients. Similar results
were observed with mobilisation and bowel action. There was no statistical
difference in complications in both groups at 3 months (range 1 to12).
Conclusion: Application of ERP to radical cystectomy has been successfully
used. We demonstrate an improved recovery and earlier discharge.
0943: CAN ACUTE RENAL COLIC PRESENTATIONS BE ANTICIPATED
DURING THE DAY? A PROSPECTIVE ANALYSIS OF CT-KUB SCANS IN
A BUSY EMERGENCY DEPARTMENT
Joseph El-Sheikha, Andrew Myatt. Castlehill Hospital, Cottingham, UK
Background: Renal colic is a common urological emergency and can place
a large burden on limited health resources. At our institution if a renal colic
is suspected a patient undergoes a CT-KUB in the Emergency department
prior to referral. We aim to determine if the presentation of renal colic to
the emergency department can be anticipated and therefore assist
organisational planning.
Method:Aprospective analysis of all suspected renal colic patientswithaCT-
KUB scanbetweenAugust andDecember 2011wasundertaken.We recorded
demographics, Urine dip, Time of CT-KUB and Stone size (if present).
Results: Data from 217 patients was recorded and 93 patients showed CT-
KUB evidence of ureteric calculi. Most CT-KUB's were preformed between
1400-1600(33/217) and least between 0200-0400 (11/217). The greatest
number of calculi were diagnosed between 1000-1200(9/93) and least 02-
0400(4/93). Overall, between0800 and2000,169/217 (78%) CT-KUBrequests
weremade and69/93 (74%) stones diagnosed.Anaverage of 18.6 calculiwere
diagnosed amonth (12-24) fromamonthly average of 43.4 CT-KUBs (33-52).
Conclusion: Suspected renal colic is less likely to present to the Emergency
department during the night but a signiﬁcant proportion of calculi and CT-
KUB scans present at this time.
0967: THE SUCCESS AND LIMITATION OF ROBOTIC ASSISTED
INTRAVESICAL URETERIC REIMPLANTATION
Jun-Hong Lim, Nicholas Gattas, Azad Najmaldin. Leeds General Inﬁrmary,
Leeds, UK; Robotic technology is increasingly being used in surgical
procedures. We present our early experience of robotic intravesical ureteric
reimplantation
All children who had ureteric reimplantation from April to July 2011 were
included in this prospective study. Patient demographics, indications for
surgery, vesicoureteric reﬂux grade, total operating time and console time,
reason for conversion to open surgery, timing of discharge and compli-
cations were noted.
8 ureters in 5 patients (age 26 months - 7 years) were operated. Reﬂux
grade of 3 to 5 in all but 1 who had a symptomatic grade 1 following deﬂux
